
ABSTRACT Objective This study aims to provide a new perspective for understanding the mechanisms of chronic rhinosinusitis with nasal polyps (CRSwNP) by comparing tissue expression and serum levels of HGF and its receptor HGF‐R (c‐MET) in patients with CRSwNP to controls, assessing the correlation of tissue and serum levels in each group and assessing them as potential new biomarkers in CRSwNP. Methods Patients aged ≥ 18 years who underwent FESS for CRSwNP in Istanbul University Istanbul Faculty of Medicine between 15 October 2021 and 15 January 2022 were included with healthy controls. Tissue mRNA expression levels of HGF and c‐MET were analysed using qPCR. Serum protein levels were measured using ELISA. Disease severity was assessed using Meltzer and Lund‐Mackay systems. Quality of life was evaluated with SNOT‐22. Results Tissue HGF mRNA expression was significantly lower, while tissue c‐MET mRNA expression, blood eosinophil levels and SNOT‐22 scores were significantly higher in patients compared with controls ( p < 0.001, p = 0.039, p < 0.001, p < 0.001, respectively). Serum HGF and c‐MET protein levels did not differ significantly between groups ( p = 0.962, p = 0.465). No significant correlation was observed between tissue mRNA expression and serum protein levels of HGF and c‐MET. Conclusions To our knowledge, this study is the first to compare both tissue mRNA and serum protein levels of HGF/c‐MET in CRSwNP. Altered tissue mRNA expression of HGF and c‐MET suggests dysregulation of the HGF/c‐MET pathway in CRSwNP. Serum protein levels did not reflect local tissue expression, indicating limited utility as non‐invasive biomarkers. Eosinophil levels of patients were significantly higher.
ABSTRACT Objectives To quantify within‐subject change in symptom, laryngoscopic and quality‐of‐life measures after 8 weeks of adjunctive nebulised N‐acetylcysteine ( NAC ) in adults with laryngopharyngeal symptoms ( LPS ) persisting despite proton‐pump‐inhibitor ( PPI ) therapy, and to explore baseline predictors of response. Design Prospective, single‐arm, pre–post interventional study. Setting Tertiary otolaryngology practice. Participants Seventy‐five adults with LPS persisting after ≥ 12 weeks of PPI therapy (baseline Reflux Symptom Index [ RSI ] ≥ 13 and Reflux Finding Score [ RFS ] ≥ 7); ambulatory reflux monitoring was not performed. Main Outcome Measures Change in RSI (primary). Secondary: RFS, the 12‐item Reflux Symptom Score (RSS‐12) and the laryngopharyngeal reflux health‐related quality‐of‐life instrument (LPR‐HRQoL). Treatment response (≥ 50% RSI reduction or end‐of‐treatment RSI < 13) was modelled by logistic regression. Results All outcomes improved at Week 8: RSI −10.2 points (95% CI −11.2 to −9.2; Cohen's d_z = −2.33), RFS −6.1 (d_z = −1.88), RSS ‐12 − 33.9 (d_z = −1.30) and LPR ‐ HRQoL +20.0 (d_z = +2.17) (all p < 0.001). Thirty‐nine of 75 (52.0%) were responders. A twice‐daily PPI regimen was independently associated with response (adjusted odds ratio [ OR ] 4.96, 95% CI 1.41–17.43; p = 0.012) and higher baseline RSI with non‐response (adjusted OR 0.70 per point, 95% CI 0.56–0.87; p = 0.002). Conclusions Nebulised NAC with saline was associated with large improvements across symptom, laryngoscopic and quality‐of‐life domains in adults with LPS persisting despite PPI therapy and was well tolerated. As the study was uncontrolled and the saline vehicle may itself relieve symptoms, efficacy requires confirmation in a randomised trial against nebulised saline.
Introduction Risk factors for unsuccessful healing of a tympanic membrane perforation following myringoplasty lack consensus. Large cohort studies are missing. Methods Data were collected for myringoplasties (with/without concomitant ossiculoplasty) performed the years 2014-2019 with a follow-up visit using the Swedish Quality Register for Ear Surgery (SwedEar). Risk factors for unsuccessful surgical outcome, defined as non-healed tympanic membrane at follow-up, were calculated using logistic regression. Results The study population included 3622 cases and 12.8% had a non-healed tympanic membrane at follow-up. The most commonly used graft material was fascia, used in 94.6% of the cases. Of the analysed variables, prior ear surgery (adjusted (a)OR 1.43, p = 0.005), age younger than 8 years (aOR 1.73, p = 0.015), a postoperative infection within 6 weeks after surgery (aOR 1.92, p < 0.001) and the surgical aim of achieving a dry/infection free ear (aOR 1.53, p = 0.045) were predictors for unsuccessful healing. For simultaneous ossiculoplasty at surgery, there was a significantly higher chance of having a healed tympanic membrane (aOR 1.49, p = 0.016). For other variables such as gender, operated side, season, graft material, perioperative antibiotics and infection free status at surgery, there was no significant effect on tympanic membrane healing. Conclusion The present evaluation of the surgical results in SwedEar constitutes one of the largest studies on myringoplasty outcome. The results showed that the age of the patient, surgical aim, prior ear surgery and postoperative infection constituted risk factors for unsuccessful healing after myringoplasty. Surprisingly, ears requiring a concomitant ossiculoplasty had a higher healing rate.
Background Antibiotics are frequently prescribed for acute exacerbations of chronic rhinosinusitis (CRS). However, antimicrobial resistance presents a challenge for the ongoing and future management of CRS patients.Objective This study aims to examine the current and past microbiological yield and antimicrobial resistance profile in a tertiary sinus centre.Methodology A retrospective results review for the calendar years from 2015 to 2018 and 2019 to 2024 was conducted on all CRS patients who had sinonasal microbiological samples taken during their outpatient visits with a history of previous endoscopic sinus surgery (ESS).Results A total of 706 cultures were analysed from 338 patients. Clinically significant organisms were identified in 60.0% of cases in 2015-2018 and 71.9% of cases in 2019-2024 (p = 0.003). Whilst Staphylococcus aureus remained the predominant isolate in both groups, Gram-negative organisms rose significantly (32.9%-46.5%, p = 0.004), particularly non-Pseudomonas and Enterobacteriaceae species. Interestingly, classical acute bacterial rhinosinusitis pathogens (Staphylococcus pneumoniae, Moraxella catarrhalis, Haemophilus influenzae) were detected in only 28.0% and 23.8% of cases in the respective study periods. Resistance to clarithromycin in S. aureus isolates increased significantly from 12.1% to 27.5% (p = 0.0008), whilst resistance to doxycycline and amoxicillin also rose, though these changes were not statistically significant. Resistance to co-amoxiclav increased from 0.3% to 3.2% in 2019-2024. (p = 0.0276).Conclusion There has been an increase in the incidence of Gram-negative bacteria as well as antibiotic resistance in CRS sinonasal cultures. These findings emphasise the importance of endoscopically guided cultures and culture-directed antibiotic therapy when managing postoperative CRS exacerbations.
Objectives To report early outcomes following implementation of a da Vinci Single-Port transoral robotic surgery (SP-TORS) programme in the United Kingdom. To provide contextual benchmarking, outcomes were compared with a historical institutional cohort treated using transoral laser microsurgery (TLM).Design Retrospective institutional series with comparison against a historical cohort using stabilised inverse-probability-of-treatment weighting.Setting High-volume UK Tertiary Head and Neck Centre.Participants All patients undergoing SP-TORS between April 2024 and September 2025. Comparative analyses were limited to oncological resections and included 33 SP-TORS and 61 TLM cases.Main Outcome Measures Feasibility, peri-operative safety, postoperative haemorrhage, return to theatre, mortality, length of stay, time to oral diet, margin status and adjuvant therapy use.Results Sixty-six patients underwent SP-TORS. All procedures were completed transorally without unplanned conversion or peri-operative mortality. Postoperative haemorrhage occurred in 4.5%, with one return to theatre. Length of stay did not differ between groups. Time to oral diet was longer following SP-TORS (adjusted ratio 1.51, p= 0.005). ASCO-defined involved margins were similar (OR 0.30, 95% CI 0.06-1.56; p = 0.15), whereas specimen ink-positive margins were less frequent following SP-TORS (OR 0.31, 95% CI 0.11-0.91; p = 0.03). A sensitivity analysis using propensity-matched T1/T2 pairs demonstrated a consistent directional effect, though this did not reach significance in the smaller matched cohort. Adjuvant therapy use was comparable.Conclusion SP-TORS implementation in a high-volume UK centre was feasible and safe during early adoption, with low complication rates. Peri-operative and early functional outcomes were broadly comparable with TLM. Although specimen ink-positive margins were less frequent following SP-TORS, interpretation should be cautious given the historical comparator and associated differences in departmental workflow. These findings support safe integration of SP-TORS into transoral surgical practice and justify prospective evaluation.